Loading organizations...
§ Private Profile · Minneapolis, MN, USA
Molecularly-targeted imaging for precise cancer tissue identification.
Vergent Bioscience has raised $30.2M across 2 funding rounds.
Vergent Bioscience has raised $30.2M in total across 2 funding rounds.
Vergent Bioscience has raised $30.2M in total across 2 funding rounds.
Vergent Bioscience's investors include Margo Shoup, Colle Capital, Intuitive Ventures, Rex Health Ventures, Windham Venture Partners.
Vergent Bioscience has raised $30.2M across 2 funding rounds. Most recently, it raised $21.5M Series B in October 2022.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Oct 4, 2022 | $21.5M Series B | Margo Shoup | Colle Capital, Intuitive Ventures, REX Health Ventures, Windham Venture Partners | Announced |
| Jun 12, 2018 | $8.7M Series A | — | — | Announced |